order to elucidate the role of substance P in adrenal nerve activity, the effects of substance P antagonists on 1) tonic activity of the adrenal sympa thetic nerve, 2) the response to exogenous substance P and 3) cutaneo-adrenal nerve reflex were investigated in anesthetized rats. Substance P or its antagonist [(Arg', D-Trp7'9, Leu" )-substance P: spantide] was injected into the subara chnoid space via polyethylene tubing.
Abstract-In
order to elucidate the role of substance P in adrenal nerve activity, the effects of substance P antagonists on 1) tonic activity of the adrenal sympa thetic nerve, 2) the response to exogenous substance P and 3) cutaneo-adrenal nerve reflex were investigated in anesthetized rats. Substance P or its antagonist [(Arg', D-Trp7'9, Leu" )-substance P: spantide] was injected into the subara chnoid space via polyethylene tubing.
Intrathecal administration of spantide (0.1 10 iig) produced a slight and transient increase in tonic activity of the adrenal nerve. Thereafter, a marked and prolonged decrease in adrenal nerve activity was observed, along with a decrease in arterial blood pressure.
Intrathecally adminis tered substance P (0.1-10 ieg) produced a marked increase in tonic activity of the adrenal nerve in a dose-related manner. This substance P-induced increase in adrenal nerve activity was significantly antagonized by pretreatment with spantide. It was also found that spantide depressed the reflex response in adrenal nerve activity evoked by noxious mechanical pinching of the skin. These findings suggest the possibility that on the spinal level, substance P has an important role in the maintenance of tonic activity of the adrenal nerve and the transmission of nocicep tive information to the adrenal nerve in rats.
The undecapeptide substance P is present in numerous intrinsic neural pathways throughout the central nervous system (1) (2) (3) (4) and the peripheral nervous tissues (5, 6) . Much evidence has accumulated supporting the suggestion that substance P has an excitatory role in neural transmission involving spinal nociceptive pathways (7 12) . Recently, this peptide has gained interest as a blood pressure regulating neuropeptide because of its localization in brain areas involved in cardiovascular control such as the medulla oblongata and the hypothalamus (13) (14) (15) . Furthermore, it has been reported that substance P neurons originating in the ventral medulla oblongata project to the intermediolateral cell column in the spinal cord (16) , from which the preganglionic sympathetic nerve originates (17) . This evidence raises the possibility that substance P may be involved in the control of sympa thetic nerve activity.
(D-Arg', D-Trp7'9, Leu")-substance P belongs to a series of full length substance P analogues with amino acid substitution. This compound, which was named as spantide by Folkers, blocked the contractile effect of substance P on isolated guinea pig taenia coli in a competitive manner with little or no agonistic action and histamine releasing action (18) , and it antagonized substance P binding in the central nervous system (19) . Using this antagonist, we undertook the present experiments to elucidate the role of substance P in adrenal sympathetic nerve activity in anesthetized rats. In this study, the following three aspects of the effects of spantide were studied: 1) effect on tonic activity of the adrenal sympathetic nerve, 2) antagonism to exogenous substance P induced response of adrenal nerve activity, and 3) effect on adrenal nerve activity evoked by noxious mechanical stimulation of the skin (cutaneo-anrenal nerve reflex).
Materials and Methods
Animals: Adult male Wistar rats, weighing 360 to 470 g, were anesthetized with a chloralose and urethane (50 mg/kg and 500 mg/kg, i.p., respectively) with a supplemental dose given intravenously as needed. After immobilization with gallamine triethiodide (10-20 mg/kg, i.v., Sigma Chemical Com pany), respiration was maintained with a tracheal cannula which was connected to an artificial respirator (model 131, Princeton Medical Instruments, Inc., Natick, MA). Rectal temperature was maintained between 37'C and 38'C with a DC current heating pad. Blood pressure and heart rate were monitored continuously via the right femoral artery.
Drugs: Substance P (Peptide Institute, Inc.) and (D-Arg1, D-Trp7'9, Leul i )-substance P (spantide, synthetized by M. Fujino and C. Kitada) were dissolved in artificial cere brospinal fluid containing bovine serum albumin (20) to give a stock solution of 2 mg/ ml. This solution was divided in small samples which were kept frozen until used. Further dilutions were made with 0.9% saline before using. The test solutions were injected into the subarachnoid space via polyethylene tubing, which was inserted through an incision in the atlantoocipital membrane to the caudal region of the thoratic enlargement (T 10). The injection volume was 5 /el, flushed with 10 il of saline. Correct placement of the cannula in the spinal cord was verified by an intrathecal injection of black dye after the animal had been sacrificed.
Adrenal nerve recordings: The left adrenal branches from the splanchnic nerve were dissected retroperitoneally and cut near the adrenal gland. Efferent nerve mass discharges were recorded from the central cut end of the nerve with bipolar platinum-iridium wire electrodes.
Adrenal nerve activity was amplified, passed through a window dis criminator in order to pick out discharges from background noise, and counted every 10 sec (Channel Selector 5-1526, Nihon Kohden) (21) . Cutaneous stimulation: Noxious mecha nical stimulation was performed by pinching skin areas of approximately 1 cm2 with a surgical clamp (about 5 kg force). Pinching was applied to different cutaneous segmental areas: the lower chest from whose spinal segments the adrenal nerves emerge (22) and the hindpaw whose spinal segments are distal to the segments of the adrenal sympa thetic outflow (23) . These cutaneous areas were stimulated for 1 min, before (control period) and 10 to 30 min after spantide administration, respectively. In some cases, pinching stimulation was also applied after adrenal nerve activity had recovered. Reflex response of adrenal nerve activity to the mechanical stimulation was expressed as the percentage of change in the number of nerve impulses.
Calculation and the statistical analysis: The data are expressed as the mean+S.D. Statistical differences between two means (P less than 0.05) were determined by Student's t-test. When two or more treatment means were compared with one mean, differences between group means were determined with an analysis of variance. The critical differences of group means were assessed with the modified t-test according to Bonferroni (24) .
Results
Effect of exogenous substance P on tonic activity of the adrenal sympathetic nerve: As shown in Fig. 1 , intrathecal administration of synthetic substance P at a dose of 0.1 to 10 10 dig produced an immediate and marked increase in adrenal nerve activity. The magni tude of these excitatory responses and the delays in return were dose-related. The mean response induced by 10 ,ug substance P was significantly different from that of the vehicle administered control up to 4 min after injection. Intrathecal administration of sub stance P did not produce any significant change in arterial blood pressure or heart rate. Infusion of vehicle into the subarachnoid space had no effect on adrenal nerve activity, blood pressure and heart rate ( Table 1) .
Effect of spantide on tonic activity of the adrenal sympathetic nerve: Intrathecal administration of the substance P antagonist spantide initially caused a slight and transient increase and then a marked and prolonged decrease in tonic activity of the adrenal nerve. This spantide-induced decrease in adrenal nerve activity recovered with the lapse of time. Specimen recording and observations of adrenal nerve activity over a period of 60 min are shown in Fig. 2 . Maximum decrease in adrenal nerve activity was dose dependent and was significantly different from that in the vehicle injected group (Fig. 3) . Although simultaneously measured blood pressure and heart rate also changed with the nerve activity, some difference in time course and effective doses were observed; a significant change was observed only in the mean blood pressure of the group which received 10 ,ag of spantide ( Table 1) .
Antagonism of spantide on exogenous substance P: The effect of intrathecally administered spantide on the exogenous substance P-induced response in adrenal nerve activity was examined. Ten to 15 min after pretreatment of 10 icg of spantide or vehicle, 0.1, 1 or 10 iig of substance P was administered intrathecally.
The increase in adrenal nerve activity, which was expressed as the percent change of the activity counts before substance P injection, was compared with that of the corresponding controls: vehicle-administered controls with pre treatment of spantide or vehicle.
As shown in Fig. 4 , intrathecal injection of substance P (0.1-10 ig) caused dose dependent increases in the maximal responses of adrenal nerve activity. This substance P induced excitation in the adrenal nerve was significantly antagonized by pretreatment with 10 jig of spantide.
Effect of spantide on adrenal nerve activity evoked by noxious mechanical stimulation of the skin: Reflex responses in adrenal nerve activity elicited by cutaneous pinching were compared before and after intrathecal in jection of spantide at a dose of 10 /tg. Specimen recordings obtained from one rat are depicted in Fig. 5 . In this case, lower chest pinching was unable to produce a reflex increase in adrenal nerve activity 15 min after spantide injection. Thereafter, reflex responses showed a return to the response level before injection, accompanied with a recovery of tonic activity. As shown in Fig. 6 , increases in adrenal nerve activity elicited by both lower chest and hindpaw pinching was significantly depressed by intrathecally administered spantide.
Discussion
The present study demonstrated that substance P antagonist, spantide [(D-Arg', D-Try7'9, Leu" )-substance P], depressed tonic activity of the adrenal nerve in anes thetized rats. Blood pressure also decreased after spantide administration. Moreover, spantide antagonized the excitatory responses induced by exogenous intrathecal substance P.
It has been reported that fibers originating in the ventral medulla oblongata innervate the intermediolateral cell column of the spinal cord (25) (26) (27) , and electrical lesions of the ventral medulla oblongata including the nucleus interfascicularis hypoglossi produces a decrease in the substance P-like im munoreactivity in the intermediolateral cell column (16) . Furthermore, Takano et al. (28) reported that the stimulation of the ventral medulla oblongata by the excitotoxic agent , kainic acid, elicited a release of immunoreac tive substance P in the spinal cord superfusion samples.
This release of substance P correlated with the rise in blood pressure. These facts suggest that the substance P like neurons of the ventral medulla may play a role in maintaining vasomotor tone. Concerning tonic activity of the adrenal nerve, Araki et al. (23) suggested that some excitatory control from the supraspinal structures to the adrenal medulla exists in animals with an intact central nervous system, since adrenal sympathetic nerve Fig. 4 . Antagonism of spantide to the exogenous substance P-induced excitatory effect on the adrenal nerve activity in rats. Animals were divided into two groups: the vehicle-pretreatment group (oper column) and the 10 pg spantide-pretreated group (hatched column). Substance P was injected intra thecally 10 to 15 min after pretreatment with vehicle or spantide.
In the control groups (vehicle-pre treated control and the spantide-pretreated control groups), vehicle was injected intrathecally 10 to 1 E min after pretreatment with vehicle or spantide.
Each value indicates the mean+S.D. The abscissa iE the maximum response, which is expressed as the percentage of change in the adrenal nerve activity from the value obtained before intrathecal substance P. The number of animals is given in parentheses *P<0 .05, **P<0.01 vs. the vehicle-pretreated control group or the spantide-pretreated control group. $P<0 .05. HHP<0.01 vs. the corresponding groups which were administered substance P alone. activity and catecholamine secretion from the adrenal medulla were markedly reduced by acute spinal transection, and these were accompanied with a decrease in arterial blood pressure.
Accordingly, our finding that spantide decreased adrenal nerve activity suggests that intrinsic substance P may have a critical role in maintenance of the tonic activity of the adrenal nerve.
The reason for the slight increase in adrenal nerve activity as well as in blood pressure for several minutes after spantide injection was not clarified in the present study. However, it possibly may be due to an interaction with other peptides on the superficial laminae of the spinal cord. Furthermore, it is possible that the agonistic action of spantide may be related to the spantide-induced initial increase in adrenal nerve activity.
The present study also demonstrated that spantide depressed the reflex response in adrenal nerve activity which was elicited by noxious mechanical stimulation of the skin. Yaksh et al. (29) demonstrated that the activation of nociceptive sensory afferents releases substance P-like immunoreactivity from the cat spinal cord. This evidence leads us to suggest that substance P may be involved in the transmission of noxious peripheral stimuli to the adrenal nerve and that the spantide-induced decrease in cutaneo-adrenal nerve reflex may be due to its antagonistic action to the intrinsic substance P.
It has been reported that the reflex response elicited by lower chest pinching is mediated via both supraspinal and spinal structures and the reflex response elicited by hindpaw pinching is mainly mediated via the supraspi nal structures in rats with an intact central nervous system (23, 30) . Our finding that spantide depressed the cutaneo-adrenal nerve reflex independently on the cutaneous segmental areas stimulated (lower chest or hindpaw)
suggests the possibility that spantide may inhibit the transmission of nociceptive information to the adrenal nerve on the descending substance P neurons from the supraspinal structures to the inter mediolateral cell column of the spinal cord, rather than on the primary afferent neurons in the dorsal horn of the spinal cord. It is also possible that the intrinsic substance P inter neurons of the spinal cord, which can be activated by descending medullary pathways (31, 32) , may be involved in these effects of spantide. However, more detailed interaction studies are required, since our previous reports indicated that the cutaneo-adrenal nerve reflex was also modified by clonidine and morphine (33, 34) .
In the present study, it was found that spantide significantly inhibited the exogenous substance P-induced excitatory response in adrenal nerve activity. However, there is a need for more research concerning the specificity of substance P antagonists because it has also been reported that spantide antagonized a bombesin-like peptide binding in the central nervous system (19) , and other tachykinin families such as neurokinin A or B exist in the rat spinal cord (35) .
In summary, the present study demon strated that spantide depressed the tonic activity of the adrenal nerve. Exogenous substance P, which was administered intra thecally, caused an excitatory response in adrenal nerve activity, and this response was blocked by the pretreatment with intrathecal spantide. These results indicate the possibility that the spantide-induced decrease in tonic activity of the adrenal nerve is due to the blocking action of endogenous substance P. It was also found that spantide depressed the reflex in adrenal nerve activity evoked by noxious cutaneous pinching. These findings suggest that on the spinal level, substance P has a role not only in maintenance of the tonic activity of the adrenal nerve, but also in the transmission of nociceptive information to the adrenal nerve in rats.
